Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stanley T. Crooke currently holds 2,021 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley T. Crooke has been a net seller of IONS stock. They have purchased $3.0M and sold $96.2M worth of shares.
Stanley T. Crooke's most recent insider trade was on Jan 26, 2021, when they sold 28,333 shares at $63.74 per share.
Stanley T. Crooke serves as Executive at IONIS PHARMACEUTICALS INC (IONS). They have executed 589 insider transactions totaling $99.2M over their tenure at the company.
Stanley T. Crooke holds the position of Executive at IONIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Stanley T. Crooke has shown a selling trading pattern, with $3.0M in total purchases and $96.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stanley T. Crooke was on Sep 22, 2020, when they sold $2.5M worth of IONS shares. This transaction involved 50,000 shares at $50.41 per share.
Stanley T. Crooke currently owns 2,021 shares of IONIS PHARMACEUTICALS INC (IONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stanley T. Crooke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stanley T. Crooke has 589 Form 4 filings on record as an insider at IONIS PHARMACEUTICALS INC.
Set alerts for Stanley T. Crooke and 40,000+ other insiders.